Clinical Trials Logo

Traumatic Arthritis clinical trials

View clinical trials related to Traumatic Arthritis.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03250767 Terminated - Clinical trials for Rheumatoid Arthritis

Clinical Evaluation of the Integra® Titan™ Modular Shoulder System Generation 2.5 for Primary Shoulder Joint Replacement

Start date: August 1, 2017
Phase:
Study type: Observational

A post market, prospective, non-randomized, multi-center, open-label, clinical study using survivorship as the reference performance goal to study the safety and efficacy of the Titan Modular Shoulder System 2.5 when used for primary shoulder arthroplasty.

NCT ID: NCT03247023 Terminated - Clinical trials for Rheumatoid Arthritis

Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement

Start date: September 18, 2017
Phase:
Study type: Observational

This study will evaluate the long term performance and safety data for the Cadence™ Total Ankle System (CTAS) when used for primary arthroplasty in patients with primary arthritis (e.g. degenerative disease), secondary arthritis (e.g. post-traumatic, avascular necrosis, if minimally 2/3 of the talus is preserved), and systemic arthritis of the ankle (e.g. rheumatoid arthritis, hemochromatosis)

NCT ID: NCT02820766 Terminated - Osteoarthritis Clinical Trials

Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting

Start date: September 2016
Phase: N/A
Study type: Observational

The primary objective of the study is to determine how the short-term outcome of subjects implanted with the JOURNEY™ II BCS Total Knee System compares to subjects implanted with other PS total knee systems, and to determine if there is a difference in health care resources consumed that may result in economic savings to patients, the facility and/or the payer. To address the study objectives, patient self-assessment questionnaires, and other objective measures of post-operative function and health care resource utilization will be used for data collection.

NCT ID: NCT02175576 Terminated - Clinical trials for Rheumatoid Arthritis

Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System

GK9B
Start date: October 2014
Phase: N/A
Study type: Interventional

Randomized Controlled Study to determine if preservation of ligaments provides increased functional ability post-operatively in comparison to traditional TKA which sacrifices soft tissue.

NCT ID: NCT01551472 Terminated - Osteoarthritis Clinical Trials

Post Market Study of the 3DKnee™ With E-plus Insert

e-plus
Start date: April 2012
Phase:
Study type: Observational

The purpose of this study is to evaluate the use and efficacy of the 3DKnee™ System using Vitamin E UHMWPE tibial inserts for total knee replacement surgery.

NCT ID: NCT00764803 Terminated - Clinical trials for Rheumatoid Arthritis

3DKnee™ System vs. the MJS Knee System

Start date: January 2008
Phase: Phase 4
Study type: Observational

The purpose of this study is to compare the survivorship and efficacy of the Encore 3DKnee™ system with that of the Encore MJS™ Knee System in a group of 600 patients for whom data collection is already under way.

NCT ID: NCT00715026 Terminated - Osteoarthritis Clinical Trials

Trilogy AB Acetabular Hip System Post Approval Study

Start date: April 2009
Phase: Phase 4
Study type: Interventional

This is a post-approval study with prospective enrollment in the United States and a retrospective enrollment outside the United States to obtain functional, quality of life and radiographic data, which will facilitate assessment of the clinical performance of the Zimmer Trilogy AB Acetabular Hip System.

NCT ID: NCT00579059 Terminated - Clinical trials for Rheumatoid Arthritis

Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia

Start date: May 2004
Phase: N/A
Study type: Interventional

The purpose of this prospective clinical data collection is to compare the outcomes of two different tibial bearings: the Maxim® Pop-Top® Tibia and Maxim® Modular Tibia.